Expert buy, hold and sell recommendations from our team of analysts.
The AI witch hunt eased up this week but the rotation out of tech into non-tech has been the dominant driver for some weeks. But it raises the question: how long will anti-tech forces prevail?
Results season throws up surprises across the board. The ASX is powering ahead, but the market is rotating fast!
There’s value emerging in REA Group and CAR Group as long-term bets.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains that Pilbara Minerals (PLS) now appears to be expanding out of its recent price contraction, which means that it should rally from here and go on to make new highs above $5.
Is the US market now underperforming the rest of the world? Should I be looking at ETFs other than IHVV? If Stokes and his partner are now offering $32.75 for BlueScope, why are the shares trading under $30? How did the brokers react to BHP’s profit report? Is there a single source where dividend amounts, dates and franking advice is easily available?
Is the US market now underperforming the rest of the world? Should I be looking at ETFs other than IHVV? If Stokes and his partner are now offering $32.75 for BlueScope, why are the shares trading under $30? How did the brokers react to BHP’s profit report? Is there a single source where dividend amounts, dates and franking advice is easily available?
Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing a hijacking of great businesses by market 'terrorists' that we could make money out of?
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.